Status:
COMPLETED
Effect of an Environmental Health Education Program on Pregnant Women in Order to Reduce Endocrine Disruptor Exposition
Lead Sponsor:
Poitiers University Hospital
Conditions:
Pregnancy
Endocrine System
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Endocrine disruptors are known as a cancer cause. On pregnant women, it can induce major foetal pathology and impact growth. Among those molecules, bisphenol-A (BPA) is a plasticizer that can be foun...
Eligibility Criteria
Inclusion
- Patients over 18
- Patients living in Poitiers or city around (near the immersive environment)
- Patients on pregnancy and who declared their pregnancy to the authority
- Patients who planned to give birth in Poitiers's hospital, Châtellerault's hospital or Clinique Fief de Grimoire, in Poitiers.
- Patients giving her agreement
Exclusion
- Patients planning to move during the study
- Patients under legal protection
- Patients expecting twins
- Patients unable to speak french
- Patients willing to give birth in another hospital than those mentionned before
Key Trial Info
Start Date :
April 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2020
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT03233984
Start Date
April 19 2017
End Date
September 28 2020
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Poitiers
Poitiers, France, 86000